Skip to main content
Full access
Research Article
Published Online: 1 January 2012

Postpartum Depression: Advances in Recognition and Treatment

Abstract

The postpartum period is a time of increased vulnerability for depression in women. Women with a prior psychiatric history are at increased risk for postpartum depression. Other risk factors include psychological, social, and biological contributions.

Abstract

The postpartum period is a time of increased vulnerability for depression in women. Women with a prior psychiatric history are at increased risk for postpartum depression. Other risk factors include psychological, social, and biological contributions. In addition to depressive symptoms, episodes of postpartum depression are often characterized by marked anxiety. Untreated symptoms of postpartum depression can have significant effects on the maternal-infant relationship as well as on the development of the child. Treatment necessitates a multimodal approach, with consideration given to education, support, psychotherapy, and biological treatment options. When pharmacological treatment is considered, the role of breast-feeding must also be taken into account. Early identification and intervention for the symptoms of postpartum depression are imperative to assure the well-being of the mother, child, and family.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

History

Published online: 1 January 2012
Published in print: Winter 2012

Authors

Affiliations

Notes

Address correspondence to Dr. Rita Suri, UCLA Mood Disorders Research Program, 300 Medical Plaza, Suite 1544, Los Angeles, CA 90095; e-mail: [email protected]

Funding Information

Author information and CME Disclosure
Rita Suri, M.D., Department of Psychiatry, Mood Disorders Research Program, University of California at Los Angeles, Semel Institute for Neuroscience and Human Behavior, Los Angeles.
Dr. Suri reports no competing interests.
Lori Altshuler, M.D., Department of Psychiatry, Mood Disorders Research Program, University of California at Los Angeles, Semel Institute for Neuroscience and Human Behavior, Los Angeles.
Advisory Board: Forest 2008, Sepracor 2010; Consultant: Eli Lilly 2010.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Focus

PPV Articles - Focus

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share